Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 93 points (0.6%) at 15,285 as of Wednesday, Sept. 11, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,438 issues advancing vs. 1,461 declining with 119 unchanged. The Services sector currently sits up 0.2% versus the S&P 500, which is up 0.1%. Top gainers within the sector include Synnex Corporation ( SNX), up 21.2%, Pandora Media ( P), up 4.4%, Fleetcor Technologies ( FLT), up 3.2%, Computer Sciences Corporation ( CSC), up 3.1% and Marriott International ( MAR), up 3.0%. On the negative front, top decliners within the sector include Sears Holdings Corporation ( SHLD), down 3.0%, United Continental Holdings ( UAL), down 2.2%, Royal Philips ( PHG), down 1.0%, Delta Air Lines ( DAL), down 0.9% and Macy's ( M), down 0.8%. TheStreet would like to highlight 5 stocks pushing the sector higher today: 5. CVS Caremark ( CVS) is one of the companies pushing the Services sector higher today. As of noon trading, CVS Caremark is up $0.50 (0.8%) to $59.72 on average volume. Thus far, 1.7 million shares of CVS Caremark exchanged hands as compared to its average daily volume of 4.5 million shares. The stock has ranged in price between $59.24-$59.82 after having opened the day at $59.24 as compared to the previous trading day's close of $59.22. CVS Caremark Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. CVS Caremark has a market cap of $72.2 billion and is part of the retail industry. Shares are up 22.5% year to date as of the close of trading on Tuesday. Currently there are 12 analysts that rate CVS Caremark a buy, no analysts rate it a sell, and 2 rate it a hold. TheStreet Ratings rates CVS Caremark as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CVS Caremark Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.